Skip to main content

Table 4 Predictors of HPV 16 and/or 18 infections among study participants

From: High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting

Variable

HPV 16 and/or 18

OR (95% CI)

P value

AOR (95% CI)

P value

Positive

Total

n (%)

N (%)

Age (years)

      

 25–34

6 (30.0)

20 (100.0)

1

 

1

 

 35–44

19 (44.2)

43 (100.0)

1.85 (0.60–5.72)

0.287

3.00 (0.80–11.18)

0.103

 45–54

22 (46.8)

47 (100.0)

2.05 (0.67–6.26)

0.206

2.65 (0.69–10.27)

0.158

  ≥ 55

6 (19.4)

31 (100.0)

0.56 (0.15–2.07)

0.385

0.90 (0.17–4.74)

0.896

Number of pregnancies*

 0

7 (77.8)

9 (100.0)

1

 

1

 

 1–3

25 (40.3)

62 (100.0)

0.19 (0.04–1.01)

0.051

0.09 (0.01–0.92)

0.043

 4–6

17 (33.3)

51 (100.0)

0.14 (0.03–0.76)

0.023

0.07 (0.01–0.73)

0.026

  ≥ 7

4 (21.1)

19 (100.0)

0.08 (0.01–0.52)

0.009

0.05 (0.00–0.65)

0.022

HIV Viral load (copies/ml)

  < 1000

29 (41.4)

70 (100.0)

1

 

1

 

  ≥ 1000

21 (33.9)

62 (100.0)

0.72 (0.36–1.47)

0.372

0.85 (0.38–1.88)

0.683

  1. *Likelihood ratio p value for number of pregnancies = 0.049
  2. OR odd ratio, AOR adjusted odds ratio, CI confidence interval